Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Ferrari

Showing results (401-410 of 547) with videos related to

Pageof 55
Sort By:
Genome Medicine|May 6, 2016
Epigenetic changes mediated by polycomb repressive complex 2 and E2a are associated with drug resistance in a mouse model of lymphomaColin Flinders, Larry Lam, Liudmilla Rubbi, et al.
Circulation. Genomic and Precision Medicine|March 11, 2020
Lamin A/C Missense Mutation R216C Pinpoints Overlapping Features Between Brugada Syndrome and LaminopathiesAnnarita Armaroli, Cristina Balla, Cecilia Trabanelli, et al.
Elife|September 1, 2017
Correction: In vivo targeting of de novo DNA methylation by histone modifications in yeast and mouseMarco Morselli, William A Pastor, Barbara Montanini, et al.
Nature Reviews. Cardiology|September 8, 2017
Expert consensus document: A 'diamond' approach to personalized treatment of anginaRoberto Ferrari, Paolo G Camici, Filippo Crea, et al.
Cell Host & Microbe|December 20, 2014
Adenovirus small E1A employs the lysine acetylases p300/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infectionRoberto Ferrari, Dawei Gou, Gauri Jawdekar, et al.
Journal of Cellular and Molecular Medicine|October 30, 2010
Circulating stem cell vary with NYHA stage in heart failure patientsCinzia Fortini, Barbara Toffoletto, Alessandro Fucili, et al.
Circulation|February 9, 2005
Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) studyMarco Valgimigli, Claudio Ceconi, Patrizia Malagutti, et al.
European Heart Journal|December 20, 2015
How can the European Society of Cardiology ensure compliance with ethical standards?Maarten L Simoons, Jean-Pierre Bassand, Jeroen Bax, et al.
Circulation|July 14, 2004
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failureMarco Valgimigli, Gian Matteo Rigolin, Alessandro Fucili, et al.
Plos One|July 23, 2014
Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patientsPaul R Kalra, Xavier García-Moll, José Zamorano, et al.
Pageof 55

Showing results (401-410 of 547) with videos related to

Sort By:
Pageof 55
Genome Medicine|May 6, 2016
Epigenetic changes mediated by polycomb repressive complex 2 and E2a are associated with drug resistance in a mouse model of lymphomaColin Flinders, Larry Lam, Liudmilla Rubbi, et al.
Circulation. Genomic and Precision Medicine|March 11, 2020
Lamin A/C Missense Mutation R216C Pinpoints Overlapping Features Between Brugada Syndrome and LaminopathiesAnnarita Armaroli, Cristina Balla, Cecilia Trabanelli, et al.
Elife|September 1, 2017
Correction: In vivo targeting of de novo DNA methylation by histone modifications in yeast and mouseMarco Morselli, William A Pastor, Barbara Montanini, et al.
Nature Reviews. Cardiology|September 8, 2017
Expert consensus document: A 'diamond' approach to personalized treatment of anginaRoberto Ferrari, Paolo G Camici, Filippo Crea, et al.
Cell Host & Microbe|December 20, 2014
Adenovirus small E1A employs the lysine acetylases p300/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infectionRoberto Ferrari, Dawei Gou, Gauri Jawdekar, et al.
Journal of Cellular and Molecular Medicine|October 30, 2010
Circulating stem cell vary with NYHA stage in heart failure patientsCinzia Fortini, Barbara Toffoletto, Alessandro Fucili, et al.
Circulation|February 9, 2005
Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) studyMarco Valgimigli, Claudio Ceconi, Patrizia Malagutti, et al.
European Heart Journal|December 20, 2015
How can the European Society of Cardiology ensure compliance with ethical standards?Maarten L Simoons, Jean-Pierre Bassand, Jeroen Bax, et al.
Circulation|July 14, 2004
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failureMarco Valgimigli, Gian Matteo Rigolin, Alessandro Fucili, et al.
Plos One|July 23, 2014
Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patientsPaul R Kalra, Xavier García-Moll, José Zamorano, et al.
Pageof 55